• The Precision Peptide Company expanded details on an exclusive strategic marketing agreement with MMA.INC that gives it exclusive marketing rights across MMA.INC’s global combat sports platform.
• Net revenue from MMA-sourced customer sales will be split 50/50 for the first 12 months, shifting to a 75/25 split in Precision’s favor for the rest of the term.
• The agreement includes a 12-month post-termination revenue-sharing tail on sales to MMA-referred customers.
• Precision will sell U.S.-manufactured, third-party-tested peptide products into MMA.INC’s ecosystem of more than 5 million social followers, about 530,000 user profiles, 75,000 active students, and more than 800 verified gyms.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Precision Peptide Company Inc. published the original content used to generate this news brief on May 21, 2026, and is solely responsible for the information contained therein.